Opus Genetics reports gene therapy trial data for two eye diseases
Go back to Opus Genetics reports gene therapy trial data for two eye diseases| Diversified Corporate Resources, Inc. (NASDAQ: IRD) | Delayed: 3.70 -0.12 (3.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.82 | 52 Week High | $0.02 | |||
| Open | $3.79 | 52 Week Low | $0.02 | |||
| Day High | $3.83 | P/E | N/A | |||
| Day Low | $3.67 | EPS | $0.00 | |||
| Volume | 117,189 | |||||



